Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
LUCY	INNOVATIVE EYEWEAR INC	$6.15M	-82.30%	-76.80%	-76.26%	-219.10%	0.09	11.98	22.80%	-328.00%	-327.98%
KYNB	KYNTRA BIO INC	$29.65M	-126.40%	124.20%	213.12%	161.40%	-7.02	3.71	82.70%	-182.60%	-182.34%
ALMS	ALUMIS INC	$2.77B	-75.50%	-57.60%	-60.04%	-105.60%	0.27	6.01	100.00%	-1,108.20%	-1,146.94%
HSDT	HELIUS MEDICAL TECHNOLOGIES INC	$83.43M	N/A	-301.80%	-78.20%	-423.30%	-4.12	40.03	49.60%	-39,358.90%	-39,291.07%
CCRN	CROSS COUNTRY HEALTHCARE INC	$269.29M	-3.80%	-2.80%	-3.08%	-6.80%	0.32	3.45	20.20%	-1.40%	-1.23%
PEPG	PEPGEN INC	$466.80M	-84.10%	-65.60%	-53.08%	-125.70%	0.17	13.15	N/A	N/A	N/A
XNCR	XENCOR INC	$824.08M	-20.40%	-14.50%	-12.25%	-9.80%	0.39	6.00	100.00%	-87.10%	-63.85%
EOLS	EVOLUS INC	$284.56M	N/A	-26.20%	-24.65%	-22.30%	-8.62	2.02	65.80%	-20.50%	-13.13%
SNSE	SENSEI BIOTHERAPEUTICS INC	$11.52M	-80.00%	-67.50%	-104.06%	-104.00%	0.20	5.81	N/A	N/A	N/A
PLYX	POLARYX THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	0.13	8.77	N/A	N/A	N/A
SCLX	SCILEX HOLDING CO	$61.21M	N/A	-282.80%	389.82%	198.70%	-2.54	0.05	68.60%	-931.20%	-802.32%
SDGR	SCHRODINGER INC	$856.72M	-48.20%	-24.20%	-34.32%	-39.30%	1.03	3.25	58.20%	-68.50%	-67.93%
OCGN	OCUGEN INC	$449.74M	-491.20%	-99.20%	-163.12%	-157.50%	15.30	1.85	100.00%	-1,192.20%	-1,131.02%
NTRA	NATERA INC	$29.16B	-25.10%	-17.70%	-22.15%	-55.50%	0.46	3.27	63.70%	-14.60%	-14.43%
ASTH	ASTRANA HEALTH INC	$1.08B	1.30%	0.60%	4.39%	9.60%	2.17	1.40	10.30%	0.30%	2.43%
FATE	FATE THERAPEUTICS INC	$154.57M	-56.60%	-40.20%	-49.47%	-40.10%	0.47	7.87	100.00%	-2,187.10%	-2,187.11%
GRDX	GRIDAI TECHNOLOGIES CORP	$9.82M	-888.30%	-16.40%	-4.86%	-9.10%	2.03	2.62	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$144.88M	-80.80%	-62.70%	-94.14%	-69.20%	0.38	5.54	100.00%	-1,690.40%	-1,690.54%
ALGS	ALIGOS THERAPEUTICS INC	$41.11M	-132.40%	-74.30%	-84.18%	-123.30%	0.53	4.70	100.00%	-3,267.60%	-2,792.71%
TWST	TWIST BIOSCIENCE CORP	$3.24B	-16.60%	-12.20%	-13.55%	-20.90%	0.40	3.78	51.60%	-19.60%	-19.30%
JBIO	JADE BIOSCIENCES INC	$639.69M	-49.00%	-44.70%	-36.20%	-139.20%	0.13	9.01	N/A	N/A	N/A
MGX	METAGENOMI INC	$54.82M	-43.20%	-31.10%	-41.23%	-34.60%	0.39	6.42	100.00%	-287.10%	-291.26%
IVA	INVENTIVA SA	$581.63M	N/A	-284.90%	-93.27%	-121.40%	-21.09	2.96	100.00%	-1,767.30%	-638.55%
HYPR	HYPERFINE INC	$106.89M	-103.90%	-80.50%	-127.79%	-353.30%	0.55	3.63	46.10%	-378.20%	-378.17%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$339.76M	-33.30%	-28.40%	-32.73%	-29.60%	0.19	14.96	N/A	N/A	N/A
XGN	EXAGEN INC	$75.01M	-138.20%	-36.90%	-30.92%	-39.40%	2.46	4.08	59.90%	-29.90%	-24.27%
BNGO	BIONANO GENOMICS INC	$11.19M	-86.40%	-49.80%	-68.74%	-66.70%	0.59	2.12	46.00%	-134.40%	-134.24%
ECOR	ELECTROCORE INC	$49.09M	-474.00%	-78.10%	-150.68%	-148.50%	-20.96	1.43	86.00%	-47.50%	-46.82%
ROIV	ROIVANT SCIENCES LTD	$19.39B	-18.30%	-15.60%	-14.29%	-20.80%	0.06	30.66	91.20%	-6,079.90%	-5,446.60%
LBRX	LB PHARMACEUTICALS INC	$610.21M	N/A	N/A	N/A	N/A	0.03	47.60	N/A	N/A	N/A
PRTA	PROTHENA CORP PUBLIC LTD CO	$482.32M	-72.70%	-62.50%	-79.27%	-3,639.10%	0.20	6.61	100.00%	-2,379.60%	-2,025.72%
MDGL	MADRIGAL PHARMACEUTICALS INC	$11.07B	-41.50%	-26.20%	-27.97%	-32.00%	1.18	3.44	95.30%	-39.00%	-36.67%
ZLAB	ZAI LAB LTD	$2.22B	-25.80%	-17.70%	-25.28%	-96.60%	0.53	2.87	61.30%	-46.80%	-45.75%
MDWD	MEDIWOUND LTD	$227.20M	-62.10%	-27.10%	-24.94%	-55.90%	0.88	2.65	18.50%	-98.40%	-81.22%
OKYO	OKYO PHARMA LTD	$67.30M	N/A	-123.50%	183.14%	79.90%	-2.36	0.58	N/A	N/A	N/A
URGN	UROGEN PHARMA LTD	$964.26M	N/A	-71.00%	-102.36%	-74.20%	-2.60	3.99	88.00%	-170.60%	-151.45%
BKD	BROOKDALE SENIOR LIVING INC	$3.95B	-267.90%	-5.00%	-1.07%	-0.50%	-894.08	0.84	19.80%	-9.50%	-1.79%
MDXH	MDXHEALTH SA	$17.37M	-1,078.00%	-20.00%	-11.21%	-8.80%	-19.67	1.14	64.50%	-30.50%	-11.21%
NIVF	NEWGENIVF GROUP LTD	$121.99k	N/A	N/A	N/A	N/A	0.23	3.43	N/A	N/A	N/A
SOPH	SOPHIA GENETICS SA	$322.27M	-93.90%	-46.60%	-54.45%	-109.90%	1.69	2.80	67.50%	-102.30%	-93.99%
THAR	THARIMMUNE INC	$166.11M	-588.40%	-264.40%	-167.25%	641.10%	0.25	4.99	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.63B	-31.10%	-28.90%	-34.06%	-31.40%	0.09	11.46	88.30%	-764.00%	-765.89%
COYA	COYA THERAPEUTICS INC	$97.30M	-57.40%	-49.70%	-67.50%	-49,060.60%	0.17	8.73	100.00%	-462.30%	-480.32%
GLSI	GREENWICH LIFESCIENCES INC	$349.69M	-1,042.80%	-565.50%	-891.35%	1,235.40%	0.74	2.35	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$598.34M	-47.40%	-38.10%	-43.51%	-245.30%	0.32	15.42	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$450.14M	-28.80%	-28.10%	-32.23%	-40.80%	0.03	32.67	100.00%	-4,386.40%	-4,366.77%
TPST	TEMPEST THERAPEUTICS INC	$10.48M	-310.90%	-125.10%	-261.69%	-289.60%	1.70	2.30	N/A	N/A	N/A
SI	SHOULDER INNOVATIONS INC	$269.06M	N/A	N/A	N/A	N/A	0.20	11.09	N/A	N/A	N/A
OGI	ORGANIGRAM GLOBAL INC	$171.62M	4.90%	3.30%	1.01%	1.60%	0.44	2.73	35.60%	6.50%	1.57%
OCS	OCULIS HOLDING AG	$1.61B	-81.70%	-61.80%	-77.18%	-150.90%	0.29	4.47	100.00%	-36,145.10%	-35,938.25%
PSNL	PERSONALIS INC	$761.05M	-38.30%	-28.30%	-35.67%	-37.50%	0.42	4.82	26.70%	-106.90%	-106.69%
IMMP	IMMUTEP LTD	$404.53M	-36.90%	-34.30%	-42.57%	-130.80%	0.09	11.69	100.00%	-594.60%	-594.28%
CRON	CRONOS GROUP INC	$1.01B	3.40%	3.10%	-0.57%	-2.60%	0.04	22.46	43.40%	27.30%	-4.88%
ADCT	ADC THERAPEUTICS SA	$517.81M	N/A	-55.40%	-50.64%	-97.80%	-2.22	4.63	92.70%	-222.00%	-153.31%
PMI	PICARD MEDICAL INC	$106.87M	N/A	N/A	N/A	N/A	0.70	2.16	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$154.93M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
NUVB	NUVATION BIO INC	$2.02B	-55.00%	-38.10%	-39.44%	-42.00%	0.85	8.48	54.30%	-813.10%	-786.53%
AIRS	AIRSCULPT TECHNOLOGIES INC	$112.39M	-21.80%	-9.00%	-9.08%	-10.60%	1.26	0.51	58.90%	-11.40%	-9.32%
PRCT	PROCEPT BIOROBOTICS CORP	$1.57B	-21.70%	-16.30%	-17.68%	-34.50%	0.35	8.44	64.50%	-28.20%	-26.98%
RANI	RANI THERAPEUTICS HOLDINGS INC	$155.53M	N/A	-129.00%	273.69%	-132.60%	-2.81	0.26	100.00%	-2,359.60%	-2,053.83%
NKTX	NKARTA INC	$146.32M	-27.70%	-22.20%	-25.13%	-21.80%	0.26	15.24	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$98.87M	-150.10%	-95.90%	-76.14%	728.50%	0.19	6.45	N/A	N/A	N/A
ALT	ALTIMMUNE INC	$469.14M	-54.80%	-47.60%	-40.73%	-92.80%	0.18	17.18	100.00%	-559,433.30%	-558,900.00%
CARL	CARLSMED INC	$297.31M	N/A	N/A	N/A	N/A	0.26	12.03	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$1.55B	-24.90%	-24.00%	-20.41%	-34.80%	0.03	32.95	N/A	N/A	N/A
XCUR	EXICURE INC	$24.76M	-108.80%	-52.90%	-73.84%	-897.50%	1.20	1.96	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$24.18M	-92.40%	-75.70%	-77.48%	3,325.10%	0.18	6.50	100.00%	-304.50%	-303.47%
TRVI	TREVI THERAPEUTICS INC	$1.30B	-31.20%	-29.30%	-24.11%	-50.10%	0.05	21.93	N/A	N/A	N/A
OPK	OPKO HEALTH INC	$936.60M	-13.70%	-8.70%	-2.63%	-5.60%	0.53	3.70	35.30%	-28.10%	-7.49%
SYRE	SPYRE THERAPEUTICS INC	$2.79B	-31.20%	-26.80%	-32.51%	-35.40%	0.11	10.91	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$4.00B	-29.10%	-26.90%	-30.36%	-211.70%	0.08	12.57	100.00%	-627.30%	-627.28%
TLPH	TALPHERA INC	$36.96M	-125.80%	-61.60%	-45.00%	-69.20%	0.60	6.83	100.00%	-44,242.90%	-44,242.86%
PTGX	PROTAGONIST THERAPEUTICS INC	$5.16B	6.90%	6.30%	7.32%	8.50%	0.09	13.05	100.00%	21.90%	22.98%
AMWL	AMERICAN WELL CORP	$91.53M	-35.90%	-25.70%	-38.02%	-2,197.70%	0.32	3.37	53.30%	-38.40%	-38.21%
DBVT	DBV TECHNOLOGIES SA	$700.13M	-295.60%	-135.20%	-204.90%	-4,670.60%	1.09	1.80	100.00%	-2,273.90%	-2,271.65%
EVMN	EVOMMUNE INC	$983.55M	N/A	N/A	N/A	N/A	-0.06	7.87	N/A	N/A	N/A
GALT	GALECTIN THERAPEUTICS INC	$176.66M	N/A	-269.90%	24.43%	-70.60%	-1.09	0.09	N/A	N/A	N/A
ACHC	ACADIA HEALTHCARE COMPANY INC	$1.51B	3.50%	1.70%	4.43%	4.70%	1.00	1.44	34.40%	3.30%	7.99%
LONA	LEONABIO INC	$17.31M	-107.10%	-89.90%	-138.45%	-509.90%	0.12	9.70	N/A	N/A	N/A
KIDS	ORTHOPEDIATRICS CORP	$427.57M	-13.00%	-9.40%	-8.79%	-12.50%	0.41	7.40	71.70%	-20.10%	-17.79%
AYTU	AYTU BIOPHARMA INC	$23.29M	-107.20%	-19.70%	-37.96%	-254.40%	7.59	1.16	66.80%	-39.00%	-34.20%
WOK	WORK MEDICAL TECHNOLOGY GROUP LTD	$15.44k	-6.80%	-3.10%	-2.12%	-2.00%	0.65	1.71	23.80%	-10.90%	-4.57%
TNDM	TANDEM DIABETES CARE INC	$1.28B	-118.80%	-22.30%	-31.71%	-18.80%	5.58	2.44	53.20%	-20.20%	-19.59%
HTFL	HEARTFLOW INC	$1.90B	N/A	N/A	N/A	N/A	0.43	8.66	N/A	N/A	N/A
ATRA	ATARA BIOTHERAPEUTICS INC	$32.37M	-41.80%	39.30%	225.66%	52.50%	-1.82	1.02	81.60%	15.40%	17.99%
MBX	MBX BIOSCIENCES INC	$1.77B	-29.30%	-28.10%	-20.75%	-42.40%	0.03	32.96	N/A	N/A	N/A
SION	SIONNA THERAPEUTICS INC	$1.70B	-33.40%	-22.70%	-21.45%	-27.40%	0.06	25.61	N/A	N/A	N/A
KALV	KALVISTA PHARMACEUTICALS INC	$757.69M	N/A	N/A	N/A	N/A	19.00	7.22	N/A	N/A	N/A
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$154.50M	N/A	-128.00%	-167.23%	-955.80%	-5.78	2.79	54.70%	-1,380.70%	-1,378.12%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.77B	-160.60%	-49.60%	-64.57%	-38.50%	3.78	4.64	95.40%	-279.30%	-253.32%
EWTX	EDGEWISE THERAPEUTICS INC	$3.18B	-30.90%	-29.40%	-27.99%	-33.30%	0.04	26.51	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$179.47M	-55.20%	-49.90%	-42.88%	-210.80%	0.09	9.89	34.30%	-963.40%	-963.38%
CVM	CEL SCI CORP	$40.43M	-226.10%	-102.20%	-130.17%	-116.00%	1.06	1.40	N/A	N/A	N/A
NBY	NOVABAY PHARMACEUTICALS INC	$68.05M	113.90%	54.80%	159.05%	529.50%	1.67	2.00	54.60%	114.60%	114.59%
KYMR	KYMERA THERAPEUTICS INC	$6.10B	-33.40%	-28.60%	-28.61%	-33.60%	0.17	7.38	100.00%	-674.80%	-674.04%
SSII	SS INNOVATIONS INTERNATIONAL INC	$776.42M	-50.40%	-27.90%	-29.04%	-34.60%	0.76	2.29	48.30%	-51.00%	-41.86%
LUNG	PULMONX CORP	$61.46M	-77.60%	-37.90%	-45.97%	-50.10%	1.30	4.86	73.30%	-61.90%	-57.87%
CNTX	CONTEXT THERAPEUTICS INC	$214.08M	-30.90%	-29.60%	-36.12%	8,256.50%	0.08	13.10	N/A	N/A	N/A
MXCT	MAXCYTE INC	$74.67M	-23.50%	-20.20%	-23.12%	-22.10%	0.18	7.74	80.00%	-132.60%	-132.58%
CMPX	COMPASS THERAPEUTICS INC	$1.14B	-48.90%	-42.50%	-30.07%	-58.90%	0.10	17.82	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	610	+1.46%	+0.32%	-0.48%	-29.81%	203.20x	5.16x	-23.77%	-9.51%	-6.53%	+67.37%	Strong Buy
Diagnostics & Research	56	-0.40%	-4.39%	-12.07%	+6.08%	16.70x	3.97x	-4.44%	+6.36%	+11.82%	+22.58%	Buy
Drug Manufacturers - General	20	+0.36%	+2.68%	+8.12%	+28.89%	43.99x	7.33x	+100.80%	+12.44%	+21.08%	+4.47%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.04%	-0.27%	+0.71%	-27.50%	-166.20x	1.75x	+9.97%	+2.28%	+5.20%	+42.63%	Buy
Healthcare Plans	10	-0.35%	+4.19%	-12.63%	-24.67%	19.38x	1.91x	+11.67%	+3.66%	+8.52%	+20.65%	Buy
Health Information Services	54	+0.76%	-3.56%	-18.69%	-91.47%	27.39x	3.20x	+8.66%	+4.39%	+6.53%	+66.23%	Buy
Medical Care Facilities	50	-0.09%	+5.82%	+12.69%	-30.49%	16.89x	5.91x	-68.69%	+7.69%	+15.92%	+10.21%	Buy
Medical Devices	139	+1.82%	-1.81%	-5.06%	-84.07%	21.83x	3.65x	+11.89%	+7.22%	+9.67%	+41.83%	Strong Buy
Medical Distribution	10	+0.90%	+0.77%	+10.03%	+52.80%	32.39x	277.72x	-98.61%	+3.54%	+23.66%	+2.69%	Buy
Medical Instruments & Supplies	57	+0.57%	-0.94%	-3.87%	-14.92%	171.28x	3.06x	+9.60%	+8.37%	+10.83%	+23.32%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 51.92% over the past year, overperforming other healthcare stocks by 105 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -1.74% from Pediatrix Medical Group's current stock price of $21.71.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #2 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 10 out of 33 due diligence checks and has average fundamentals. Bioventus has seen its stock lose -19.35% over the past year, overperforming other healthcare stocks by 33 percentage points.

Bioventus has an average 1 year price target of $13.00, an upside of 55.13% from Bioventus's current stock price of $8.38.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #3 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: C.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 40, which is 14 points higher than the healthcare sector average of 26. It passed 13 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 139% over the past year, overperforming other healthcare stocks by 192 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $6.50, an upside of 35.98% from Ironwood Pharmaceuticals's current stock price of $4.78.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 68 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 29.06%, which is 27 percentage points higher than the healthcare sector average of 2.26%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.1%, which is 7 percentage points higher than the healthcare sector average of 2.26%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.81%, which is 6 percentage points higher than the healthcare sector average of 2.26%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.81% in the last day, and down -0.2% over the last week. Polaryx Therapeutics was the among the top gainers in the healthcare sector, gaining 64.32% yesterday.

Polaryx shares are trading higher after the company announced it selected a contract research organization for SOTERIA to evaluate PLX-200, across four different LSDs.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 68 points higher than the healthcare sector average of 18. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -32.88% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 53.58% in the past year. It has overperformed other stocks in the healthcare sector by 106 percentage points.

3. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -52.97% in the past year. It has performed in line with other stocks in the healthcare sector.

Are healthcare stocks a good buy now?

57.82% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.3% over the next year.

6.59% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.93% of healthcare stocks are rated B (Buy), 46.95% are rated C (Hold), 25.03% are rated D (Sell), and 8.5% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 59.51x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.